← Back to signals
MANE
Veradermics, Inc
Research: Finviz ↗·Perplexity ↗
No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.
Days to cover (short int.)
6.6d↑+0.3%
as of 2026-08-31
Fund 13D/13G Filings (3)
Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).
| Fund | Form | ∆ Shares | % of Class | Since Filing | Filed | Src |
|---|---|---|---|---|---|---|
| Viking Global | SC 13G/A | — | 4.5% | +5.8% vs SPY +11.3% abs | 2026-05-15 | ↗ |
| Citadel Advisors | SC 13G | NEW | 4.5% | -2.3% vs SPY +3.2% abs | 2026-05-07 | ↗ |
| Viking Global | SC 13G | NEW | 5.8% | — | 2026-02-12 | ↗ |
Tracked Funds Holding (2)
| Fund | Manager | Shares Held | Position Value |
|---|---|---|---|
| Viking Global | Andreas Halvorsen | 1.6M | $192M |
| Maverick Capital | Lee Ainslie | 790K | $97M |
Quarter-end 13F positions for the tracked funds holding this stock.